Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

“…The synthesized particles mainly consist of 100 nm-scale CeO₂ with 10 nm-scale Pt and aggregation of small CeO₂ less than 10 nm with highly dispersed Pt at a maximum flame temperature <i>T</i>_max ≈ 1800 K. …”

Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

“…The synthesized particles mainly consist of 100 nm-scale CeO₂ with 10 nm-scale Pt and aggregation of small CeO₂ less than 10 nm with highly dispersed Pt at a maximum flame temperature <i>T</i>_max ≈ 1800 K. …”

Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

“…The synthesized particles mainly consist of 100 nm-scale CeO₂ with 10 nm-scale Pt and aggregation of small CeO₂ less than 10 nm with highly dispersed Pt at a maximum flame temperature <i>T</i>_max ≈ 1800 K. …”

HPK1-IN-3 decreased T lymphocyte activation. by Min Jeong Ahn (18886882)

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

Mtb infection leads to significant decrease in the number of ASC specks-positive cells which is independent of the ESX-1 secretion system. by Shivangi Rastogi (11204172)

Decreased membrane localization of myrGFP in <i>ACBD6</i>-deficient cells. by Eric Soupene (64584)

The SW480 cells were treated with the S100A1 (blue, Lanes 2, 3 and 4). by Md. Imran Khan (4853302)

“…<p>Decrease in fold was observed when treated with the complex of 100 nM S100A4-S100A1 (green) and value of <i>p</i> is considering as <i>p</i> ≤ 0.05.…”

Transmission, transmittance, and absorbance of surgical PPE in the range of 360-370nm. by Rachael Guenter (15147776)

MCF-7 cells were treated with 0, 10, or 20 μM of Peptide 1 or Peptide 2 for 48h. by Deepu Dowarha (5673440)

Subjects:

S100A1 complete sequence indicating highlighted region selected for peptide construction, attaching it to HIV-TAT peptide forming Peptide 1 and its scramble arrangement in Peptide... by Deepu Dowarha (5673440)

Subjects:

Fig 9 - by Deepu Dowarha (5673440)

Subjects:

The p53-MDM2 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Subjects:

Analysis of WST-1 assay. by Deepu Dowarha (5673440)

Subjects:

The ¹H−¹⁵N HSQC spectra overlay of free ¹⁵N p53 (1–73) (red) and in complex with unlabelled S100A1 (yellow). by Deepu Dowarha (5673440)

Subjects:

Fig 16 - by Deepu Dowarha (5673440)

Subjects:

Competitive binding experiment. by Deepu Dowarha (5673440)

Subjects:

The MCF-7 and/or MDA-MB-468 cells were treated with or without 10 μM Peptide 1 for 48h. by Deepu Dowarha (5673440)

Subjects:

The p53-Peptide 1 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Subjects:

Rescue of <i>MBNL</i>1 e5 and <i>MBNL</i>2 e5 and e8 mis-splicing by erythromycin lactobionate treatment at 10 DPI. by Mougina K. Eltahir (12988153)